Congress Reopens the Government—and Reignites Prohibition - Cato Institute
Congress Reopens the Government—and Reignites Prohibition Cato Institute
Real-time CBD & hemp news from 16+ industry sources. Updated every 2 hours.
Congress Reopens the Government—and Reignites Prohibition Cato Institute
Senate Rejects Attempt To Save Hemp Industry From THC Ban In Key Spending Bill Marijuana Moment
Minnesota AG's letter to Congress worries hemp industry FOX 9 Minneapolis-St. Paul
FDA issues warning letters to companies selling unapproved CBD products American Veterinary Medical Association
Congressional hearing on FDA and CBD zeroes in on intoxicating hemp products HempToday
Hemp Industry Expert Tells Congress Businesses Are 'Begging' For Federal Regulations At FDA-Focused Committee Hearing Marijuana Moment
Senate Democrat unveils legislation giving FDA oversight on CBD safety standards The Hill
Use of Cannabidiol (CBD) for PD symptoms American Parkinson Disease Association
Congressional Leaders Seek Stakeholder Input Regarding CBD Regulation Holland & Knight
FDA Passes the Buck (Back) to Congress for Legislative Solution on CBD Regulation Wilson Sonsini
FDA declines to regulate CBD products and calls on Congress for fix rules for the growing market Milwaukee Independent
FDA: Congress, not rule-making, likely route for CBD availability American Veterinary Medical Association
Citing too many unknowns, FDA decides against regulating CBD in food, supplements National Restaurant Association
FDA asks Congress to legislate CBD approval pathway, as new law permits marijuana & CBD research www.hoganlovells.com
FDA declines to regulate CBD and calls on Congress for a fix Los Angeles Times
After 4-year review, FDA shuts down attempt to regulate CBD as a supplement and asks Congress for help AgencyIQ by POLITICO
FDA indicates need to better regulate CBD products and plans to work with Congress on new rules CNN
FDA Hires Cannabis Policy Expert: Is a New CBD Regulatory Framework Around the Corner? regulatoryoversight.com
Advocacy: Medical Cannabis and CBD Epilepsy Foundation
FDA Regulation of Cannabidiol (CBD) Consumer Products: Overview and Considerations for Congress Every CRS Report
Showing 41–60 of 60 stories tagged #policy